Clinical Trial Update: An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure Chamber [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of TOLAMBA for ragweed-allergic rhinitis conducted in an environmental exposure chamber has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Seasonal Ragweed

Drugs mentioned

• TOLAMBA

Snippet

Sponsor: Dynavax Technologies Corporation | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED